Neurones Net Assets

Latest as of December 2025: €464.87 Million EUR ≈ $543.48 Million USD

Neurones net assets. Based on the latest financial reports, Neurones (NRO) has net assets worth €464.87 Million EUR (≈ $543.48 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€749.03 Million ≈ $875.70 Million USD) and total liabilities (€284.16 Million ≈ $332.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Neurones annual equity growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€464.87 Million
% of Total Assets	62.06%
Annual Growth Rate	10.03%
5-Year Change	31.72%
10-Year Change	94.95%
Growth Volatility	3.2

Net Assets of Neurones (2000–2025)

Net assets of Neurones from 2000 to 2025. This chart illustrates how Neurones's net assets have evolved over time, based on quarterly financial data. See Neurones (NRO) net asset quality to measure how much of total assets are equity-financed.

Annual Net Assets for Neurones (2000–2025)

The table below shows the annual net assets of Neurones from 2000 to 2025. For live market cap and overall valuation, see Neurones market cap and net worth.

Year	Net Assets	Change
2025-12-31	€464.87 Million ≈ $543.48 Million	+6.58%
2024-12-31	€436.17 Million ≈ $509.93 Million	+6.93%
2023-12-31	€407.91 Million ≈ $476.89 Million	+8.61%
2022-12-31	€375.58 Million ≈ $439.09 Million	+6.42%
2021-12-31	€352.92 Million ≈ $412.60 Million	-1.70%
2020-12-31	€359.02 Million ≈ $419.74 Million	+9.69%
2019-12-31	€327.32 Million ≈ $382.67 Million	+10.63%
2018-12-31	€295.88 Million ≈ $345.91 Million	+10.38%
2017-12-31	€268.05 Million ≈ $313.38 Million	+12.41%
2016-12-31	€238.46 Million ≈ $278.78 Million	+10.52%
2015-12-31	€215.75 Million ≈ $252.23 Million	+9.59%
2014-12-31	€196.88 Million ≈ $230.17 Million	+12.37%
2013-12-31	€175.21 Million ≈ $204.84 Million	+12.73%
2012-12-31	€155.42 Million ≈ $181.70 Million	+11.71%
2011-12-31	€139.13 Million ≈ $162.65 Million	+14.67%
2010-12-31	€121.33 Million ≈ $141.84 Million	+12.05%
2009-12-31	€108.28 Million ≈ $126.59 Million	+11.73%
2008-12-31	€96.91 Million ≈ $113.30 Million	+12.83%
2007-12-31	€85.89 Million ≈ $100.41 Million	+12.26%
2006-12-31	€76.51 Million ≈ $89.45 Million	+8.30%
2005-12-31	€70.65 Million ≈ $82.60 Million	+9.20%
2004-12-31	€64.70 Million ≈ $75.64 Million	+9.74%
2003-12-31	€58.96 Million ≈ $68.93 Million	+8.96%
2002-12-31	€54.11 Million ≈ $63.26 Million	+12.81%
2001-12-31	€47.97 Million ≈ $56.08 Million	+12.52%
2000-12-31	€42.63 Million ≈ $49.84 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Neurones's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 37136900000.0% over the analyzed period, indicating profitable operations and earnings retention.

Neurones Net Assets Breakdown (December 2025)

Neurones net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	€371.37 Million	92.85%
Common Stock	€9.73 Million	2.43%
Other Comprehensive Income	€3.75 Million	0.94%
Other Components	€15.13 Million	3.78%
Total Equity	€399.98 Million	100.00%

Neurones Competitors by Market Cap

The table below lists competitors of Neurones ranked by their market capitalization.

Company	Market Cap
No Va Land Investment Group Corp VN:NVL	$886.19 Million
First Community Bancshares Inc NASDAQ:FCBC	$886.33 Million
Caina Technology Co. Ltd. SHE:301122	$886.37 Million
Standard Lithium Ltd NYSE MKT:SLI	$886.39 Million
NWPX Infrastructure, Inc. NASDAQ:NWPX	$885.95 Million
Shanghai Tongji Science&Technology Industrial Co Ltd SHG:600846	$885.88 Million
Guangdong Sky Dragon Printing Ink Group Co Ltd SHE:300063	$885.75 Million
Beijing Creative Distribution Automation Co Ltd SHE:002350	$885.66 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Neurones's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 378,104,000 to 399,980,000, a change of 21,876,000 (5.8%).
Net income of 61,900,000 contributed positively to equity growth.
Dividend payments of 31,624,000 reduced retained earnings.
Share repurchases of 316,000 reduced equity.
Other comprehensive income decreased equity by 296,012,000.
Other factors increased equity by 287,928,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€61.90 Million	+15.48%
Dividends Paid	€31.62 Million	-7.91%
Share Repurchases	€316.00K	-0.08%
Other Comprehensive Income	€-296.01 Million	-74.01%
Other Changes	€287.93 Million	+71.99%
Total Change	€-	5.79%

Book Value vs Market Value Analysis

This analysis compares Neurones's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.81x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 17.64x to 2.81x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2002-12-31	€2.20	€38.90	x
2003-12-31	€2.34	€38.90	x
2004-12-31	€2.62	€38.90	x
2005-12-31	€2.89	€38.90	x
2006-12-31	€2.97	€38.90	x
2007-12-31	€3.41	€38.90	x
2008-12-31	€3.83	€38.90	x
2009-12-31	€4.35	€38.90	x
2010-12-31	€4.82	€38.90	x
2011-12-31	€5.39	€38.90	x
2012-12-31	€6.00	€38.90	x
2013-12-31	€6.73	€38.90	x
2014-12-31	€7.45	€38.90	x
2015-12-31	€8.22	€38.90	x
2016-12-31	€8.95	€38.90	x
2017-12-31	€10.00	€38.90	x
2018-12-31	€10.99	€38.90	x
2019-12-31	€12.23	€38.90	x
2020-12-31	€13.29	€38.90	x
2021-12-31	€12.85	€38.90	x
2022-12-31	€13.61	€38.90	x
2023-12-31	€14.58	€38.90	x
2024-12-31	€15.53	€38.90	x
2025-12-31	€13.84	€38.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Neurones utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 15.48%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.22%
• Asset Turnover: 1.14x
• Equity Multiplier: 1.87x
Recent ROE (15.48%) is above the historical average (11.36%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	9.14%	5.82%	1.06x	1.48x	€-361.10K
2001	11.08%	6.10%	1.15x	1.58x	€509.30K
2002	11.53%	6.43%	1.17x	1.53x	€790.80K
2003	8.70%	5.24%	1.13x	1.47x	€-725.60K
2004	8.62%	5.59%	1.04x	1.48x	€-871.50K
2005	8.64%	5.44%	1.08x	1.47x	€-935.30K
2006	9.22%	5.08%	1.10x	1.65x	€-560.90K
2007	12.04%	6.38%	1.15x	1.64x	€1.68 Million
2008	14.21%	6.85%	1.14x	1.81x	€3.85 Million
2009	12.57%	5.92%	1.28x	1.66x	€2.62 Million
2010	13.08%	6.24%	1.26x	1.66x	€3.52 Million
2011	11.44%	5.22%	1.26x	1.74x	€1.86 Million
2012	10.30%	4.71%	1.26x	1.73x	€427.00K
2013	11.48%	5.41%	1.23x	1.72x	€2.39 Million
2014	11.36%	5.77%	1.17x	1.69x	€2.45 Million
2015	10.76%	5.35%	1.14x	1.77x	€1.52 Million
2016	11.61%	5.64%	1.16x	1.78x	€3.50 Million
2017	11.24%	5.63%	1.18x	1.69x	€3.01 Million
2018	9.73%	5.30%	1.09x	1.68x	€-724.10K
2019	10.36%	6.04%	1.00x	1.72x	€1.08 Million
2020	9.58%	5.89%	0.95x	1.70x	€-1.34 Million
2021	12.10%	6.50%	1.02x	1.82x	€6.55 Million
2022	13.38%	6.65%	1.08x	1.86x	€11.18 Million
2023	13.94%	6.67%	1.10x	1.90x	€13.97 Million
2024	13.89%	6.48%	1.12x	1.92x	€14.69 Million
2025	15.48%	7.22%	1.14x	1.87x	€21.90 Million

Industry Comparison

This section compares Neurones's net assets metrics with peer companies in the Information Technology Services industry.

Industry Context

Industry: Information Technology Services
Average net assets among peers: $938,784,811
Average return on equity (ROE) among peers: 16.78%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Neurones (NRO)	€464.87 Million	9.14%	0.61x	$885.97 Million
Hitechpros (ALHIT)	$3.56 Million	39.38%	1.63x	$21.06 Million
IT Link (ALITL)	$10.18 Million	24.56%	1.62x	$26.72 Million
Keyrus SA (ALKEY)	$53.11 Million	-10.38%	4.43x	$112.89 Million
Alten SA (ATE)	$2.22 Billion	4.81%	0.64x	$2.38 Billion
Atos SE (ATO)	$2.94 Billion	8.90%	1.45x	$600.36 Million
Aubay Société Anonyme (AUB)	$202.90 Million	12.88%	0.88x	$662.40 Million
Capgemini SE (CAP)	$3.85 Billion	11.43%	1.37x	$16.85 Billion
Union Technologies Informatique Group S.A (FPG)	$3.00 Million	12.25%	4.06x	$6.69 Million
Infotel SA (INF)	$98.70 Million	9.54%	1.31x	$267.53 Million
Cheops Technology France SA (MLCHE)	$2.81 Million	54.45%	2.85x	$132.25 Million

About Neurones

PA:NRO France Information Technology Services

Market Cap

$1.09 Billion

€931.47 Million EUR

Market Cap Rank

#9137 Global

#145 in France

Share Price

€38.90

Change (1 day)

+0.91%

52-Week Range

€33.65 - €44.70

All Time High

€51.10